Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Recursion Pharmaceuticals RXRX stock surged 16% in early October 2025 on renewed AI interest despite posting $171.9 million ...
We recently published 10 Stocks Stealing Today’s Spotlight; 5 on All-Time Highs. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
At the upcoming Lived! 360 Orlando 2025 conference, Tim Purdum, Engineering Manager and Senior Software Engineer at dymaptic, ...
Zacks Investment Research on MSN
Recursion Pharmaceuticals (RXRX) Suffers a Larger Drop Than the General Market: Key Insights
Recursion Pharmaceuticals (RXRX) ended the recent trading session at $6.36, demonstrating a -6.33% change from the preceding day's closing price. This change lagged the S&P 500's daily loss of 0.63%.
Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback